These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9527807)

  • 61. Effect of probenecid and N'-methylnicotinamide on renal handling of cis-dichlorodiammineplatinum-II in rats.
    Osman NM; Litterst CL
    Cancer Lett; 1983 May; 19(1):107-11. PubMed ID: 6221790
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of traditional Chinese medicines on pharmacokinetics of levofloxacin.
    Hasegawa T; Yamaki K; Muraoka I; Nadai M; Takagi K; Nabeshima T
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2135-7. PubMed ID: 8540731
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Non-linear pharmacokinetics of ofloxacin after a single intravenous bolus dose in pigs.
    Son DS; Ikenoue N; Tagawa Y; Shimoda M; Kokue E
    J Vet Pharmacol Ther; 2000 Oct; 23(5):311-5. PubMed ID: 11107005
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Probenecid inhibition of the renal excretion of dyphylline in chicken, rat and man.
    Acara M; Carr EA; Terry EN
    J Pharm Pharmacol; 1987 Jul; 39(7):526-30. PubMed ID: 2886621
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Lack of effect of ofloxacin on theophylline pharmacokinetics in rats.
    Okazaki O; Miyazaki K; Tachizawa H
    Chemotherapy; 1987; 33(6):402-11. PubMed ID: 3480792
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The effect of cimetidine and ranitidine administration with zidovudine.
    Fletcher CV; Henry WK; Noormohamed SE; Rhame FS; Balfour HH
    Pharmacotherapy; 1995; 15(6):701-8. PubMed ID: 8602376
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Probenecid, but not cystic fibrosis, alters the total and renal clearance of fexofenadine.
    Liu S; Beringer PM; Hidayat L; Rao AP; Louie S; Burckart GJ; Shapiro B
    J Clin Pharmacol; 2008 Aug; 48(8):957-65. PubMed ID: 18511651
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Interaction between levofloxacin and vancomycin in rats--study of serum and organ levels.
    Mori H; Nakajima T; Nakayama A; Yamori M; Izushi F; Gomita Y
    Chemotherapy; 1998; 44(3):181-9. PubMed ID: 9612608
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Influence of ion pump-inhibiting drugs on the accumulation of ofloxacin and grepafloxacin in human polymorphonuclear leukocytes].
    Orero A; Cantón E; Pemán J; Velert MM; Bermejo MV
    Rev Esp Quimioter; 2002 Dec; 15(4):352-9. PubMed ID: 12587041
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Interactions between cimetidine, nitrofurantoin, and probenecid active transport into rat milk.
    Gerk PM; Oo CY; Paxton EW; Moscow JA; McNamara PJ
    J Pharmacol Exp Ther; 2001 Jan; 296(1):175-80. PubMed ID: 11123378
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of the dimeric bile acid analogue S 0960, a specific inhibitor of the apical sodium-dependent bile salt transporter in the ileum, on the renal handling of taurocholate.
    Schlattjan JH; Fehsenfeld H; Greven J
    Arzneimittelforschung; 2003; 53(12):837-43. PubMed ID: 14732964
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Drug interactions with fluoroquinolones.
    Stein GE
    Am J Med; 1991 Dec; 91(6A):81S-86S. PubMed ID: 1767807
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of cimetidine on the pharmacokinetics of proguanil in healthy subjects and in peptic ulcer patients.
    Kolawole JA; Mustapha A; Abdul-Aguye I; Ochekpe N; Taylor RB
    J Pharm Biomed Anal; 1999 Sep; 20(5):737-43. PubMed ID: 10701981
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dose related pharmacokinetics of ofloxacin in healthy volunteers.
    Immanuel C; Hemanthkumar AK; Gurumurthy P; Venkatesan P
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):1017-22. PubMed ID: 12475149
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Secretory mechanisms of grepafloxacin and levofloxacin in the human intestinal cell line caco-2.
    Yamaguchi H; Yano I; Hashimoto Y; Inui KI
    J Pharmacol Exp Ther; 2000 Oct; 295(1):360-6. PubMed ID: 10992002
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mechanisms for the renal secretion of cisplatin.
    Nelson JA; Santos G; Herbert BH
    Cancer Treat Rep; 1984 Jun; 68(6):849-53. PubMed ID: 6539649
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inhibition of oat3-mediated renal uptake as a mechanism for drug-drug interaction between fexofenadine and probenecid.
    Tahara H; Kusuhara H; Maeda K; Koepsell H; Fuse E; Sugiyama Y
    Drug Metab Dispos; 2006 May; 34(5):743-7. PubMed ID: 16455804
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The effect of cimetidine on the formation of sulfamethoxazole hydroxylamine in patients with human immunodeficiency virus.
    Lehmann DF; Newman N; Morse PD
    J Clin Pharmacol; 1998 May; 38(5):463-6. PubMed ID: 9602961
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Quinolone pharmacokinetics and metabolism.
    Lode H; Höffken G; Boeckk M; Deppermann N; Borner K; Koeppe P
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():41-9. PubMed ID: 2124212
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of probenecid on the renal excretion mechanism of a new carbapenem, DA-1131, in rats and rabbits.
    Kim SH; Kim WB; Lee MG
    Antimicrob Agents Chemother; 1999 Jan; 43(1):96-9. PubMed ID: 9869572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.